Biogen BIIB
NASDAQ BIIB
$253.40 +2.92 (+1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Biogen (BIIB) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Biogen (BIIB) recorded Depreciation & Amortization (CF) of $241.1 million in Q3 2026, up 19.2% from $202.2 million a year earlier and up 2.1% from the prior quarter.

Analysis

Biogen (BIIB) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

On a TTM basis, Biogen's Depreciation & Amortization (CF) came in at $881.8 million as of Sep 30, 2026, up 15.5% year-over-year; for FY2025, it came in at $779.9 million, up 15.8% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $673.2 million in FY2024 (+36.1%), $494.8 million in FY2023 (-4.6%), $518.4 million in FY2022 (+6.3%) and $487.7 million in FY2021 (+6.7%).
  • The Q3 2026 figure is the highest quarterly Depreciation & Amortization (CF) since Q3 2019.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for 13 consecutive quarters, with growth averaging 18.7% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 46.2% in Q3 2024, against a decline of 21.5% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $236.1 million (Q2 2026), $204.4 million (Q1 2026) and $200.2 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.12 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 192.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.58 Bn
10 Biogen 37.46 Bn 26.77 Bn 2.06 Bn 241.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 241.10 Mn
Jun 30, 2026 236.10 Mn
Mar 31, 2026 204.40 Mn
Dec 31, 2025 200.20 Mn
Sep 30, 2025 202.20 Mn
Jun 30, 2025 194.30 Mn
Mar 31, 2025 183.20 Mn
Dec 31, 2024 184.00 Mn
Sep 30, 2024 182.80 Mn
Jun 30, 2024 158.90 Mn
Mar 31, 2024 147.50 Mn
Dec 31, 2023 140.10 Mn
Sep 30, 2023 125.00 Mn
Jun 30, 2023 117.40 Mn
Mar 31, 2023 112.30 Mn
Dec 31, 2022 119.80 Mn
Sep 30, 2022 120.70 Mn
Jun 30, 2022 134.80 Mn
Mar 31, 2022 143.10 Mn
Dec 31, 2021 134.70 Mn
API Access

Biogen Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BIIB&period=max&api_key=YOUR_API_KEY